Our volunteer pipeline accelerates the development of life-saving treatments.
Our Volunteers
At INFECTA, we maintain a robust volunteer pipeline that enables us to initiate and complete studies efficiently. This operational strength directly benefits our clients through predictable timelines and reliable data delivery.
Our volunteers return to participate in multiple studies because they trust our professionalism and appreciate our facilities. This isn’t coincidental: it reflects the environment we’ve built and the standards we maintain. For pharmaceutical companies and vaccine developers, this translates into reduced recruitment delays and higher study completion rates.
Interested in participating in clinical research? Discover current opportunities at our Volunteer portal
Strong volunteer relationships are built on transparency and respect. We communicate clearly about what participation involves, including potential discomfort and the nature of early-phase research. Volunteers understand they’re contributing to something meaningful by accelerating the development of treatments and vaccines that will reach patients worldwide.
We specialize in first-in-human trials and Controlled Human Infection Models (CHIM). These complex studies require volunteers who grasp the value of clinical research. While these trials undergo rigorous ethical review and are conducted under medical supervision according to ICH-GCP R3 standards, they do involve manageable risk. Our volunteers participate knowingly and willingly because they understand both the safeguards in place and the contribution they’re making.
We believe our volunteers deserve recognition for their contribution. Society celebrates firefighters and other emergency personnel who choose to take on manageable risk for public benefit. Clinical research volunteers make the same choice. They advance treatments that will save lives and improve health outcomes for countless people around the world.
We consistently recruit to target within projected timelines. Our established volunteer base and streamlined processes mean your study starts when planned and progresses without recruitment-related delays.
Volunteers who trust the research environment are more engaged participants. They comply with protocols, attend follow-up visits, and communicate openly with study staff. This directly impacts data quality and study integrity.
First-in-human and CHIM studies demand precision. Our volunteers understand protocol requirements and the importance of their participation. Combined with our qualified personnel and purpose-built facilities, this creates an environment where complex studies are executed reliably.
Every study operates under stringent ethical oversight with fully informed consent. Volunteers can withdraw from study participation at any time, with appropriate safety follow-up as needed. This isn’t just regulatory compliance: it’s foundational to how we work. For sponsors, it means studies conducted to the highest ethical and scientific standards.
Our track record reflects decades of experience across first-in-human studies, dose-finding trials, safety and immunogenicity assessments, and pioneering work with CHIMs. When you partner with INFECTA, reliable volunteer recruitment is one component of comprehensive early-phase development support.
Volunteers are essential to generating the early-phase data that informs your development decisions, establishes safety profiles, and accelerates regulatory pathways. Our operational strength, including consistent volunteer recruitment, ensures you receive decision-quality data within the timelines your program requires.
Contact us to explore how INFECTA can support your clinical development goals.
We welcome individuals who want to contribute to medical progress through clinical research. Visit our volunteer portal to learn more about current opportunities and what participation involves.
